Hello, I was diagnosed with Multiple Myeloma in September 2023 at age 37. Upon diagnosis, they stuck a tube in neck vein to clean up my blood (apheresis) because I had hyper viscosity (thick blood) due very high IGA (7,000+) and M-spike (over 6.0) levels. After that they started me on the quadruple induction therapy (daratumumab, revlimid, Velcade, dexamethasone). The induction therapy worked for about 4 cycles before my disease developed resistance to it and my numbers became stagnant. Following this, my doctor switched me to venetoclax (400mg at first, and then 800mg) with weekly 20 mg of dexamethasone - because I have translocation 11;14. Within 60 days, venetoclax brought my M-spike down to ZERO. After my M-spike was eliminated, they did a bone marrow biopsy and found that my disease had evolved from standard risk to high risk by gaining 1q23, which is considered a high risk cytogenetic abnormality by the International Myeloma Working Group....
Has anyone had a similar experience where they started out with standard risk then evolved to high risk by gaining 1q? How has the journey been for you? Did you have a stem cell transplant, how did your disease respond to it (did you have a long remission, or did you relapse quickly)? What maintenance therapy drugs did your doctor put you on as patient with 1q? Have you experienced frequent relapses as a result of gaining 1q?
I'm having a stem cell transplant on 5 SEP 2024. If you have 1q and have had a stem cell transplant, I would love to hear about your experiences 🙏